| Primary |
| Hypertension |
33.3% |
| Type 2 Diabetes Mellitus |
25.0% |
| Cerebrovascular Accident Prophylaxis |
8.3% |
| Coronary Artery Disease |
8.3% |
| Pain |
8.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
8.3% |
| Tachyarrhythmia |
8.3% |
|
| Cerebral Haemorrhage |
25.0% |
| Local Swelling |
25.0% |
| Pain In Extremity |
25.0% |
| Renal Failure Acute |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
22.7% |
| Atrial Fibrillation |
12.9% |
| Coronary Artery Disease |
12.9% |
| Hypertension |
9.3% |
| Myocardial Infarction |
9.3% |
| Diabetes Mellitus |
5.8% |
| Cerebrovascular Accident Prophylaxis |
3.6% |
| Cardiac Failure |
3.1% |
| Vascular Graft |
2.7% |
| Anticoagulant Therapy |
2.2% |
| Drug Use For Unknown Indication |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Atrial Flutter |
1.8% |
| Systemic Lupus Erythematosus |
1.8% |
| Acute Myocardial Infarction |
1.3% |
| Myelofibrosis |
1.3% |
| Atrial Thrombosis |
0.9% |
| Cerebrovascular Accident |
0.9% |
| Coronary Artery Bypass |
0.9% |
|
| Subdural Haematoma |
11.8% |
| Vomiting |
11.8% |
| Hyponatraemia |
8.8% |
| Cerebrovascular Accident |
5.9% |
| Haemorrhage Intracranial |
5.9% |
| Melaena |
5.9% |
| Shock Haemorrhagic |
5.9% |
| Slow Response To Stimuli |
5.9% |
| Soft Tissue Haemorrhage |
5.9% |
| Angina Unstable |
2.9% |
| Blood Sodium Decreased |
2.9% |
| Cerebellar Haemorrhage |
2.9% |
| Coma |
2.9% |
| Death |
2.9% |
| Drug Abuse |
2.9% |
| Drug Ineffective |
2.9% |
| Dyspnoea |
2.9% |
| Exposure During Pregnancy |
2.9% |
| Gastric Haemorrhage |
2.9% |
| Hyperglycaemia |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.0% |
| Hypertension |
15.0% |
| Coronary Artery Disease |
7.5% |
| Rheumatoid Arthritis |
7.2% |
| Prophylaxis |
4.3% |
| Osteoporosis |
3.5% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Pain |
2.4% |
| Atrial Fibrillation |
2.3% |
| Colorectal Cancer |
2.3% |
| Diabetes Mellitus |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Acute Myocardial Infarction |
2.1% |
| Stent Placement |
1.9% |
| Parkinson's Disease |
1.8% |
| Tumour Pain |
1.7% |
| Cardiac Failure |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Breast Cancer |
1.4% |
|
| Thrombocytopenia |
10.0% |
| Renal Failure Acute |
8.1% |
| Death |
6.6% |
| Thrombosis In Device |
6.6% |
| Vomiting |
6.2% |
| Wrong Technique In Drug Usage Process |
6.2% |
| Myocardial Infarction |
5.7% |
| Urinary Tract Infection |
5.2% |
| Rhabdomyolysis |
4.7% |
| Weight Decreased |
4.7% |
| Hyponatraemia |
4.3% |
| Renal Failure |
4.3% |
| Sepsis |
4.3% |
| Pneumonia |
3.8% |
| Syncope |
3.8% |
| Subacute Hepatic Failure |
3.3% |
| Sudden Death |
3.3% |
| Tendonitis |
3.3% |
| Transient Ischaemic Attack |
3.3% |
| Cardiac Failure |
2.4% |
|
| Interacting |
| Coronary Artery Disease |
23.5% |
| Cardiac Failure |
18.2% |
| Cerebrovascular Accident |
11.4% |
| Stent Placement |
11.4% |
| Atrial Fibrillation |
6.1% |
| Cerebrovascular Accident Prophylaxis |
6.1% |
| Thrombosis Prophylaxis |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
| Arthropathy |
3.4% |
| Product Used For Unknown Indication |
1.9% |
| Angiogram |
1.5% |
| Anticoagulant Therapy |
1.1% |
| Hip Arthroplasty |
1.1% |
| Peripheral Arterial Occlusive Disease |
1.1% |
| Atrial Thrombosis |
0.8% |
| Decreased Appetite |
0.8% |
| Hypertension |
0.8% |
| Insomnia |
0.8% |
| Major Depression |
0.8% |
| Atrial Flutter |
0.4% |
|
| Lower Gastrointestinal Haemorrhage |
26.5% |
| Visual Impairment |
11.8% |
| Pallor |
8.8% |
| Vitreous Haemorrhage |
8.8% |
| Subdural Haematoma |
5.9% |
| Upper Gastrointestinal Haemorrhage |
5.9% |
| Basal Ganglia Haemorrhage |
2.9% |
| Coma |
2.9% |
| Drug Interaction |
2.9% |
| Normochromic Normocytic Anaemia |
2.9% |
| Pain In Extremity |
2.9% |
| Pericardial Effusion |
2.9% |
| Potentiating Drug Interaction |
2.9% |
| Respiratory Tract Infection |
2.9% |
| Tracheal Stenosis |
2.9% |
| Traumatic Intracranial Haemorrhage |
2.9% |
| Vomiting |
2.9% |
|
